New SEC Form D filing

Angelis Oncology, Inc., 2026-07-23

A new SEC Form D private-offering notice from San Francisco, CA, an undisclosed offering target in Biotech. The source filing is one click away.

What this filing says

Angelis Oncology, Inc. Verified via SEC Form D
Filed 2026-07-23Filed to raise Undisclosed The filer declared an indefinite offering amount; we say so instead of inventing a number.First money in 2026-07-10Raised so far $400,000HQ (as filed) San Francisco, CASector Biotech web-verified against the company’s own siteStage (inferred) Pre-seedCall status Debt-only offering
Source linked the Form D on EDGAR↗Named in the filing 1 executive & director

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.

Other Form D filings from the same week

each with its own page and its own EDGAR source